Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

Cited by (1,000)

Items 601–700 of 1,000

1. Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota
   Tianqi Cai, Xinhua Song, Xiaoxue Xu, Ling Dong, Shufei Liang, Meiling Xin, Yuhong Huang, Linghui Zhu, Tianxing Li, Xueke Wang et al. · 2024 · Frontiers in Cellular and Infection Microbiology
2. Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
   Nasir Javaid, Farzana Yasmeen, Sangdun Choi · 2019 · Pharmaceutics
3. Organ transplantation and gut microbiota: current reviews and future challenges.
   Jie Xiao, Zhao Peng, Yuxiao Liao, Hui Sun, Weiqiang Chen, Xing Chen, Zhanjie Wei, Chuanlei Yang, Andreas Klaus Nussler, Jinping Liu et al. · 2018 · Europe PMC (PubMed Central)
4. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
   Sung‐Min Won, Eunju Park, Jin‐Ju Jeong, Raja Ganesan, Haripriya Gupta, Yoseph Asmelash Gebru, SatyaPriya Sharma, Dong Joon Kim, Ki Tae Suk · 2021 · International Journal of Molecular Sciences
5. Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma
   Taotao Zhang, Yunlong Cui, Yanjin Wu, Jiahui Meng, Linmeng Han, Jiaqi Zhang, Chunyu Zhang, Chenxi Yang, Lu Chen, Xue Li Bai et al. · 2022 · Clinical and Translational Medicine
6. Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship
   Vittoria Manilla, Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani · 2023 · Microorganisms
7. Lipopolysaccharide activated TLR4/NF-κB signaling pathway of fibroblasts from uterine fibroids.
   Jing Ru Guo, Lihua Zheng, Li Chen, Ning Luo, Weihong Yang, Xiaoyan A. Qu, Mingmin Liu, Zhongping Cheng · 2015 · PubMed Central
8. Bacteria Deliver a Genotoxic Hit
   Robert F. Schwabe, Timothy Cragin Wang · 2012 · Science
9. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
   Yaqin Zhang, Weihua Cao, Shiyu Wang, Lu Zhang, Xinxin Li, Ziyu Zhang, Yao Xie, Minghui Li · 2024 · Virulence
10. Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll‐like 4 receptor signaling
    Satomi Nadanaka, Taishi Hashiguchi, Hiroshi Kitagawa · 2020 · The FASEB Journal
11. The Microbiome and Its Implications in Cancer Immunotherapy
    Hani Choudhry · 2021 · Molecules
12. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
    Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Marina Cipullo, Annachiara Coppola, Chiara Tammaro, Giuseppe Scafuro, Patrizia Iodice, Alessandro Federico · 2023 · Cancers
13. IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma
    Hor-yue Tan, Ning Wang, Sai-Wah Tsao, C. Che, Man-Fung Yuen, Yi-Bin Feng · 2016 · OncoTarget
14. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver
    Susanne Nicole Weber, Annika Bohner, Dianne H. Dapito, Robert F. Schwabe, Frank Lammert · 2016 · PLoS ONE
15. Microbial factors in inflammatory diseases and cancers
    Ong, Hong Sheng, Yim, Howard Chi Ho · 2017 · Advances in experimental medicine and biology
16. Chemokine CXCL10 Modulates the Tumor Microenvironment of Fibrosis-Associated Hepatocellular Carcinoma
    Elisa Fabiana Brandt, Maike Baues, Theresa Hildegard Wirtz, Jan‐Niklas May, Petra Fischer, Anika Beckers, Björn-Carsten Schüre, Hacer Sahin, Christian Trautwein, Twan Lammers et al. · 2022 · International Journal of Molecular Sciences
17. Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights
    Sanchita Rauth, Mokenge Peter Malafa, Moorthy Palanimuthu Ponnusamy, Surinder K. Batra · 2024 · Gastroenterology
18. Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges
    Antonio Cigliano, Weiting Liao, Giovanni Andrea Deiana, Davide Rizzo, Xin Chen, Diego Francesco Calvisi · 2024 · Biomedicines
19. Gut‑liver axis in liver disease: From basic science to clinical treatment (Review)
    Jianpeng Wang, Xinyi Wang, Enba Zhuo, Bangjie Chen, Shixin Chan · 2024 · Molecular Medicine Reports
20. SCARF-1 promotes adhesion of CD4+ T cells to human hepatic sinusoidal endothelium under conditions of shear stress
    Daniel A. Patten, Sivesh Kathir Kamarajah, Joanne M. Rose, Joseph Tickle, Emma L. Shepherd, David Adams, Chris J. Weston, Shishir Shetty · 2017 · Scientific Reports
21. Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis
    Takuma Nakatsuka, Keisuke Tateishi, Hiroyuki Kato, Hiroaki Fujiwara, Keisuke Yamamoto, Yotaro Kudo, Hayato Nakagawa, Yasuo Tanaka, Hideaki Ijichi, Tsuneo Ikenoue et al. · 2021 · Cell Death and Disease
22. The Role of the Microbiome in Liver Cancer
    Mar Moreno‐Gonzalez, Naiara Beraza · 2021 · Cancers
23. Relationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development
    Eiji Hara · 2015 · Digestive Diseases
24. Linking gut microbiota with human diseases
    Udaya Kumar Vandana · 2020 · Bioinformation
25. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma
    Yishu Tang, Hang Zhou, Yu Xiang, Fang Cui · 2020 · European Journal of Gastroenterology & Hepatology
26. The role of the gut microbiome in the development of hepatobiliary cancers
    Neil Daniel, Flavia Genua, Mazda Jenab, Ana‐Lucia Mayén, Anastasia Chrysovalantou Chatziioannou, Pekka Keski‐Rahkonen, David J. Hughes · 2023 · Hepatology
27. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
    Betül Gök Yavuz, Saumil S. Datar, Shadi Chamseddine, Yehia Ibrahim Mohamed, Michael Brian LaPelusa, Sunyoung S. Lee, Zishuo Ian Hu, Eugene Jon Koay, Hop S. Tran Cao, Prasun K. Jalal et al. · 2023 · Cancers
28. ZNT1 and Zn2+ control TLR4 and PD-L1 endocytosis in macrophages to improve chemotherapy efficacy against liver tumor
    Dan Yang, Taikun Tian, Xiaojing Li, Baokai Zhang, Linlin Qi, Fang Zhang, Mingshun Han, Shuang Wang, Jun Xiao, Yingying Gou et al. · 2023 · Hepatology
29. Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation
    Kunmin Xiao, Kexin Li, Kunlin Xiao, Jinzu Yang, Lei Zhou · 2025 · Cancer Medicine
30. Androgen Receptor (AR)-TLR4 Crosstalk Mediates Gender Disparities in Hepatocellular Carcinoma Incidence and Progression
    Qiuju Han, Dan Yang, Chunlai Yin, Jian Zhang · 2019 · Journal of Cancer
31. Dietary Protein, Fiber and Coffee Are Associated with Small Intestine Microbiome Composition and Diversity in Patients with Liver Cirrhosis
    Shehnaz K. Hussain, Tien Sy Dong, Vatche Garen Agopian, Joseph R. Pisegna, Francisco Antonio Durazo, Pedram J. Enayati, Vinay Sundaram, Jihane N. Benhammou, Mazen Noureddin, Gina Choi et al. · 2020 · Nutrients
32. Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded Vδ2Vγ9 T Cells in Hepatocellular Carcinoma Immunotherapy
    Jiajia Han, Siya Zhang, Yi Xu, Yongsheng Pang, Xue Zhang, Yu Hu, Hui Chen, Wanjun Chen, Jianmin Zhang, Wei He · 2020 · Frontiers in Immunology
33. Translocation of Helicobacter hepaticus synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis
    Huan Deng, Sureshkumar Muthupalani, Susan E. Erdman, Haibo Liu, Zhengchuan Niu, Timothy Cragin Wang, James G. Fox · 2022 · OncoImmunology
34. Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids
    Faraz Ahmad, Priyanka Saha, Vineeta Singh, Mohd Wahid, Raju K. Mandal, Bhartendu Nath Mishra, Sharmila Fagoonee, Shafiul Haque · 2022 · Food Chemistry
35. Microbiome: The bacterial tightrope
    Katherine Bourzac · 2014 · Nature
36. Immunotherapeutic properties of chemotherapy
    Carole Fournier, Thaiz Rivera Vargas, Tiffany Wormhoudt Martin, Andréa Melis, Lionel Apétoh · 2017 · Current Opinion in Pharmacology
37. The gut microbiota – A vehicle for the prevention and treatment of hepatocellular carcinoma
    Diren Beyoğlu, Jeffrey R. Idle · 2022 · Biochemical Pharmacology
38. The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy
    Xiaoqiang Qi, Yajun Liu, Samira Hussein, Grace Choi, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li · 2022 · Cells
39. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance
    Filippo Pelizzaro, Fabio Farinati, Franco Trevisani · 2023 · Biomedicines
40. Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study
    Seul Ki Han, Myung-Jae Seo, Taesic Lee, Moon Young Kim · 2024 · PLoS ONE
41. Group 3 innate lymphoid cells: regulating host–commensal bacteria interactions in inflammation and cancer
    Jérémy Goc, Matthew R. Hepworth, Gregory F. Sonnenberg · 2015 · International Immunology
42. Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model
    Kenichiro Seki, Mitsuteru Kitade, Norihisa Nishimura, Kosuke Kaji, Kiyoshi Asada, Tadashi Namisaki, Kei Moriya, Hideto Kawaratani, Yasushi Okura, Hiroaki Takaya et al. · 2018 · Oncotarget
43. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets
    Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada · 2020 · Nutrients
44. RETRACTED ARTICLE: p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs
    Hye Yeon Choi, Hifzur Rahman Siddique, Mengmei Zheng, Yi Kou, Da‐Wei Yeh, Tatsuya Machida, Chia‐Lin Chen, Dinesh Babu Uthaya Kumar, Vasu Punj, Peleg Winer et al. · 2020 · Nature Communications · Retracted
45. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome.
    R. Golonka, M. Vijay-Kumar · 2021 · Advances in Cancer Research
46. Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging
    Nao Nagai, Yotaro Kudo, Daisuke Aki, Hayato Nakagawa, Koji Taniguchi · 2021 · International Journal of Molecular Sciences
47. Microbiota and viral hepatitis: State of the art of a complex matter
    Ivana Milošević, Edda Russo, Ankica Vujović, Aleksandra M. Barac, Olja Stevanović, Stefano Gitto, Amedeo Amedei · 2021 · World Journal of Gastroenterology
48. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
    Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Rossana Fargion, Anna Ludovica Fracanzani · 2021 · Biomedicines
49. Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation
    Ze Xiang, Jian Wu, Jiarui Li, Shusen Zheng, Xuyong Wei, Xiao Xu · 2023 · Engineering
50. Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma
    Cheng Zhou, Zhangfu Yang, Bao‐Ye Sun, Yong Yi, Zheng Wang, Jian Zhou, Jia Fan, Wei Gan, Ning Ren, Shuang‐Jian Qiu · 2023 · Journal of Hepatocellular Carcinoma
51. Mechanisms by which the intestinal microbiota affects gastrointestinal tumours and therapeutic effects
    Jikai He, Haijun Li, Jiaqi Jia, Yang Liu, Ning Zhang, Rumeng Wang, Wenhao Qu, Yanqi Liu, Lizhou Jia · 2023 · Molecular Biomedicine
52. Metformin Inhibits Angiogenesis Induced by Interaction of Hepatocellular Carcinoma with Hepatic Stellate Cells
    Hongmei Qu, Xingwang Yang · 2014 · Cell Biochemistry and Biophysics
53. Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases
    Eman K. E. Anwer, Muhammad Ajagbe, Mohamed A. Sherif, Abobaker Salem Musaibah, Shuaib Mahmoud, Ali ElBanbi, Anwar Abdelnaser · 2025 · Biomedicines
54. Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
    Elisa Monti, Clara Vianello, Ilaria Leoni, Giuseppe Galvani, Annalisa Lippolis, Federica D’Amico, Sara Roggiani, Claudio Stefanelli, Silvia Turroni, Francesca Fornari · 2025 · Cells
55. The solid tumor microenvironment and related targeting strategies: a concise review
    Yingliang Wang, Huimin Zhou, Shuguang Ju, Xiangjun Dong, Chuansheng Zheng · 2025 · Frontiers in Immunology
56. The Gut‒Liver Axis in Liver Disease: Molecular Mechanisms and Therapeutic Targets
    Zhiji Chen, Siqi Liao, Suhua Wu, Siyuan Chen, Qin Tang, Li Zhou, Xiaoqin Li, Huiyi Hu, Jiayao Xu, An Zhang et al. · 2025 · MedComm
57. Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma
    Zhuo Wang, Ming Yan, Jia’an Li, Jiafu Long, Yan Li, Hongmin Zhang · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
58. Plant seed protease inhibitors differentially affect innate immunity in a tumor microenvironment to control hepatocarcinoma
    José Moisés Laparra, Claudia Mónika Haros · 2019 · Food & Function
59. Crosstalk between NLRP12 and JNK during Hepatocellular Carcinoma
    Shahanshah Khan, Hasan Zaki · 2020 · International Journal of Molecular Sciences
60. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
    Qiang Yu, Liwei Wu, Jie Ji, Jiao Feng, Weiqi Dai, Jingjing Li, Jianye Wu, Chuanyong Guo · 2020 · Journal of Hepatocellular Carcinoma
61. Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
    Xueting Wan, Mengyao Song, Aiyun Wang, Yang Zhao, Zhonghong Wei, Yin Lu · 2021 · Frontiers in Immunology
62. Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis
    Kentaro Akiyama, Eiji Warabi, Kosuke Okada, Toru Yanagawa, Tetsuro Ishii, Katsumi Kose, Katsutoshi Tokushige, Kazunori Ishige, Yuji Mizokami, Kenji Yamagata et al. · 2017 · EXPERIMENTAL ANIMALS
63. Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review
    Yi‐Hsun Chen, Wei‐Kai Wu, Ming‐Shiang Wu · 2020 · International Journal of Molecular Sciences
64. Activation of NOD1 and NOD2 in the development of liver injury and cancer
    Naoya Omaru, Tomohiro Watanabe, Ken Kamata, Kosuke Minaga, Masatoshi Kudo · 2022 · Frontiers in Immunology
65. TLR 2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF ‐κB pathway‐mediated inflammatory responses
    Bingyan Liu, Shuo Yan, Yiping Jia, Jun Ma, Shaoqiu Wu, Yuyao Xu, Shang Mingyi, Aiwu Mao · 2016 · FEBS Journal
66. MST kinases in innate immune signaling
    Zhubing Shi, Zhaocai Zhou · 2018 · Cell Stress
67. Discovery of an interplay between the gut microbiota and esophageal squamous cell carcinoma in mice.
    Man Kit Cheung, Grace Gar‐Lee Yue, Kei-Yin Tsui, Adele Joyce Gomes, Hoi Shan Kwan, Philip Wai Yan Chiu, Clara Bik‐San Lau · 2020 · PubMed Central
68. The Interaction Between the Microbiome and Tumors
    Yawen Zong, Yujie Zhou, Binyou Liao, Min Liao, Yangyang Shi, Wei Yu, Yu‐Yao Huang, Xuedong Zhou, Lei Cheng, Biao Ren · 2021 · Frontiers in Cellular and Infection Microbiology
69. Food supplements could be an effective improvement of diabetes mellitus: a review
    Xiangxi Meng, Qinyu Li, Ruyu Shi, Jiayin Chang, Hong Chang, Minhui Li · 2021 · Journal of Future Foods
70. Rubus chingii Hu. unripe fruits extract ameliorates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance
    Jianjun Wu, Dingqi Zhang, Bo Zhu, Siqi Wang, Yongbin Xu, Congcong Zhang, Hailing Yang, Shunchun Wang, Ping Liu, Luping Qin et al. · 2022 · Chinese Medicine
71. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
    Ji Ye Hyun, Seul Ki Kim, Sang Jun Yoon, Su Been Lee, Jin‐Ju Jeong, Haripriya Gupta, Satya Priya Sharma, Ki‐Kwang Oh, Sung‐Min Won, Goo-Hyun Kwon et al. · 2022 · International Journal of Molecular Sciences
72. Microbiota, immunity and the liver
    Trishan Vaikunthanathan, Niloufar Safinia, Giovanna Lombardi, Robert Ian Lechler · 2016 · Immunology Letters
73. High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer
    Yanqiu Yue, Tao Zhou, Yanjing Gao, Zongli Zhang, Li Li, Lin Liu, Wenna Shi, Lihui Su, Baoquan Cheng · 2017 · Tumor Biology
74. Combined use of alcohol in conventional chemical-induced mouse liver cancer model improves the simulation of clinical characteristics of human hepatocellular carcinoma
    Bo Xin, Ying Cui, Yanxia Wang, Lei Wang, Jipeng Yin, Licheng Zhang, Hailin Pang, Helong Zhang, Rui‐An Wang · 2017 · Oncology Letters
75. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
    Cao, Fengyan, Zhang, Yunfang, Li, Weiguang, Shimizu, Kuniyoshi, Xie, Haifeng, Zhang, Chaofeng · 2018 · International Immunopharmacology
76. Clinical Implications of the Associations Between Intestinal Microbiome and Colorectal Cancer Progression
    Yongkang Chen, Yong Yang, Jin Gu · 2020 · Cancer Management and Research
77. Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma
    Akinari Sawada, Yasuhiro Fujiwara, Yasuaki Nagami, Fumio Tanaka, Hirokazu Yamagami, Tetsuya Tanigawa, Masatsugu Shiba, Kazunari Tominaga, Toshio Watanabe, Min Gi et al. · 2016 · Digestive Diseases and Sciences
78. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis
    Takashi Yamaguchi, Katsunori Yoshida, Miki Murata, Kanehiko Suwa, Koichi Tsuneyama, Koichi Matsuzaki, Makoto Naganuma · 2022 · International Journal of Molecular Sciences
79. Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma—A Scoping Review
    Ann‐Kathrin Lederer, Hannah Rasel, Eva Kohnert, Clemens Kreutz, Roman Huber, Mohamed Tarek Badr, Patricia K. E. Dellweg, F. Bartsch, Hauke Lang · 2023 · Microorganisms
80. Microbiota-derived H2S induces c-kit+ cDC1 autophagic cell death and liver inflammation in metabolic dysfunction-associated steatohepatitis
    Yuxiang Song, Na Li, Shang Jiang, Kexin Wang, Guoyue Lv, Zhongqi Fan, Xiliang Du, Wenwen Gao, Lin Lei, Zhe Wang et al. · 2025 · Nature Communications
81. The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
    Jiali Yao, Beifang Ning, Jin Ding · 2025 · Gut Microbes
82. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment
    Hafiz Ghufran, Maryam Azam, Azra Mehmood, Hira Butt, Sheikh Amer Riazuddin · 2021 · Experimental and Molecular Pathology
83. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
    Imaad Said, Hassan Ahad, Adnan Said · 2022 · World Journal of Gastrointestinal Oncology
84. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA
    I‐Ting Chen, An-Chieh Cheng, Yiting Liu, Chieh Yan, Yi-Chen Cheng, Chiung‐Fang Chang, Ping‐Hui Tseng · 2022 · International Journal of Molecular Sciences
85. Diet, Microbiome, and Epigenetics in the Era of Precision Medicine
    Gabriela Riscuta, Dan Xi, Dudith Pierre‐Victor, Pamela E Starke-Reed, Jag H. Khalsa, Linda C. Duffy · 2018 · Methods in molecular biology
86. Polygonatum sibiricum Polysaccharide Inhibited Liver Cancer in a Simulated Tumor Microenvironment by Eliminating TLR4/STAT3 Pathway
    Yunke Xu, Yong Xia Guo, LU Chang-you, Linlin Yu, Chao Fang, Chuntao Li · 2023 · Biological and Pharmaceutical Bulletin
87. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
    Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, Lucia Cerrito, Francesco Santopaolo, Leonardo Stella, Antonio Gasbarrini, Francesca Romana Ponziani · 2024 · Nutrients
88. Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice
    Suraphan Panyod, Wei‐Kai Wu, Ya-Chi Hsieh, Yea-Jing Tseng, Sin-Yi Peng, Rou-An Chen, Huai‐Syuan Huang, Yi‐Hsun Chen, Ting‐Chin David Shen, Chi‐Tang Ho et al. · 2024 · Nutrition and Diabetes
89. Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease
    R. Nevola, L. Rinaldi, M. Giordano, A. Marrone, L. Adinolfi · 2018 · Hepatoma Research
90. Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice
    Jacopo Baglieri, Cuili Zhang, Shuang Liang, Xiao Liu, Takahiro Nishio, Sara Brin Rosenthal, Debanjan Dhar, Hua Su, Min Cong, Jidong Jia et al. · 2021 · American Journal Of Pathology
91. Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
    Qun Cai, Mingyan Zhu, Jinnan Duan, Hao Wang, Jingdan Chen, Yixin Xiao, Yangqin Wang, Jianfang Wang, Xuewen Yu, Hui Yang · 2022 · Frontiers in Oncology
92. Engineered Bacteria EcN-MT Alleviate Liver Injury in Cadmium-Exposed Mice via its Probiotics Characteristics and Expressing of Metallothionein
    Changwei Zou, Ying Chen, Hongyu Li, Wenyu Li, Jin Wei, Ziyan Li, Xinliang Wang, Tingtao Chen, Hong Hui Huang · 2022 · Frontiers in Pharmacology
93. One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma
    Hao Chen, Di Lu, Xinyu Yang, Zhihang Hu, Chiyu He, Huigang Li, Zuyuan Lin, Modan Yang, Xiao Xu · 2022 · Frontiers in Immunology
94. Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer
    Beng San Yeoh, Piu Saha, Rachel M. Golonka, Jun Zou, Jessica L. Petrick, Ahmed A. Abokor, Xia Xiao, Venugopal Reddy Bovilla, Alexis Bretin, Jesús Rivera‐Esteban et al. · 2022 · Gastroenterology
95. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings
    Bhrigu Kumar Das · 2022 · Apmis
96. TLR4-Dependent Tumor-Initiating Stem Cell-Like Cells (TICs) in Alcohol-Associated Hepatocellular Carcinogenesis
    Keigo Machida, Douglas E. Feldman, Hidekazu Tsukamoto · 2014 · Advances in experimental medicine and biology
97. The Gut Microbiota, Tumorigenesis, and Liver Diseases
    Guishuai Lv, Ningtao Cheng, Hongyang Wang · 2017 · Engineering
98. Can intestinal microbiota be associated with non-intestinal cancers?
    Camille M. Jacqueline, Lionel Brazier, Dominique Faugère, F. Renaud, Frédéric Thomas A, Benjamín Roche · 2017 · Scientific Reports
99. Generic chemoprevention of hepatocellular carcinoma
    Sai Krishna Athaluri Divakar, Yujin Hoshida · 2018 · Annals of the New York Academy of Sciences
100. Spot-light on microbiota in obesity and cancer
     Paolo Marzullo, Silvia Bettini, Davide Menafra, Sara Aprano, Giovanna Muscogiuri, Luigi Barrea, Silvia Savastano, Annamaria Colao, Annamaria Colao, Silvia Savastano et al. · 2021 · International Journal of Obesity